Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-21

Clinical Trial Update: Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluate the effects of rasagiline on sleep disturbances in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RASAGILINE (rasagiline)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Sleep Disturbances, Parkinsons's Disease | Phase 4 | Status: COMPLETED